Gene ampli®cation is frequently present in human tumors, although speci®c target genes relevant to many ampli®ed loci remain unidenti®ed. An expression cloning assay enabled identi®cation of a candidate oncogene derived from human chromosome 3p14.1. The cDNA retrieved from morphologically transformed cells contained the full-length protein coding region and detected an abundant transcript in the same cells. Sequence analysis revealed identity with the wild-type sequence of p44 S10 , a highly conserved subunit of the 26S proteasome that exhibits similarity to the Arabidopsis fus6/cop11 family of signaling molecules. p44 S10 gene copy number and mRNA expression were increased in association with segmental 1.8 ± 11-fold chromosomal gains in cutaneous malignant melanoma cell lines (5/13; 40%) and tumors (2/40; 5%), and in breast cancer MCF-7 cells. Likewise, malignant progression of human radial growth phase WM35 melanoma cells was associated with ampli®cation and increased expression of endogenous p44 S10 , and increased expression of p44 S10 was sucient to induce proliferation of WM35 cells in vivo. The results demonstrate segmental copy number gains within chromosome 3p in cutaneous malignant melanoma and suggest that deregulation of a proteasome regulatory particle subunit may contribute to the malignant phenotype. Oncogene (2000) 19, 1419 ± 1427.
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Introduction
Human tumors result from genetic alterations in oncogenes and tumor suppressor genes that code for critical growth-regulatory proteins (Vogelstein and Kinzler, 1998) . Genetic alteration of known oncogenes such as RAS or MYC family members is infrequent for certain tumor types, such that only a subset of tumors contain alteration of any known oncogene. Cutaneous malignant melanoma is a highly malignant neoplasm that remains poorly characterized with respect to oncogene genetic alterations. Comparative genomic hybridization analysis of melanoma identi®ed segmental copy number gains (gene ampli®cation) within chromosomes 4q12, 5p14.3-pter, 7q33-qter, 8q12-13, 11q13.3-14.2, and 17q25 (Bastian et al., 1998) . Nonsegmental gains were found for chromosomes 7, 8, 6p, 1q, 20 , and others. In a complementary study, hybridization with chromosome speci®c probes revealed that gain of chromosome 20q material is a frequent alteration in this tumor type (Barks et al., 1997) . While candidate genes have been identi®ed in some cases, speci®c genes relevant to these multiple ampli®ed loci remain to be identi®ed (Anzick et al., 1997) .
We observed segmental gain of chromosome 3p14 in melanoma tumors and cell lines, and identi®ed a proteasome subunit-encoding gene exhibiting several features expected of the relevant oncogene. p44 S10 maps within a minimal region commonly aected by ampli®cation, is consistently and speci®cally upregulated at the mRNA level in cell lines with ampli®cation, is similarly activated during malignant progression in the WM35 model system, and is sucient to induce proliferation of WM35 cells in vivo.
Results

Isolation of p44 S10
A cDNA library under control of the CMV promoter was prepared using mRNA from four breast cancer cell lines, and plasmid was transfected directly into RK3E cells as described in the Materials and methods. RK3E cells were previously derived from rat kidney by transfection of a genomic fragment of adenovirus type 5 E1A (Ruppert et al., 1991) . The cells are euploid and diploid, exhibit little background of spontaneous foci, and form foci in response to a small subset of known oncogenes including GLI, c-MYC, GKLF/EZF/KLF4, and activated alleles of RAS or b-catenin (Foster et al., 1999; Kolligs et al., 1999) .
Several large foci that resulted from transfection of the library were isolated and expanded in culture. PCR using¯anking vector-derived primers generated a single product of 1.3 kb in length using one cell line genomic DNA as template. This cDNA was subsequently found to be identical to a 44 kDa protein termed subunit 10 of the human 26S proteasome and is referred to as p44 S10 (Dubiel et al., 1995; Hochstrasser, 1996; Coux et al., 1996; Glickman et al., 1998a) . No inserts were retrieved from the other lines analysed, suggesting that some foci result from the AdpL conjugate used for transfection, or that the relevant genes were not retained during passage in culture.
Northern blot analysis of the RK3E-p44 S10 cells revealed two p44 S10 transcripts migrating above the endogenous rat transcript, corresponding to transcripts processed at the endogenous p44 S10 polyadenylation signal ( Figure 1a, arrow 2) or the plasmid vectorencoded signal further downstream ( Figure 1a , arrow 3). Likewise, transcripts were detected in the breast cancer cell lines used for library construction, with signi®cantly increased expression in MCF-7 cells (Figure 1b) .
Sequence analysis
Sequence analysis revealed a methionine codon in a good context for translation initiation (six bases from the 5' end of the cDNA insert, followed by an open reading frame of 1167 bases and a putative 3' untranslated region containing a polyadenylation signal AATAAA. This sequence was identical to that in Genbank Accession D14663, identi®ed previously as the human subunit 10 of the 26S proteasome regulatory particle, a multi-subunit complex that regulates core particle-mediated degradation of proteins including several oncogene or tumor suppressor gene products (Dubiel et al., 1995; Glickman et al., 1998b) .
To verify that p44 S10 and D14663 represent the entire open reading frame, additional upstream sequence was isolated as described in the Materials and methods. An antisense primer cognate to p44 S10 (5'-ctg gtt cgg ccc acg gcc ttt gcc atc att g-3'), a primer speci®c to pBKCMV sequence¯anking the insert, and the library plasmid DNA were used to amplify the p44 S10 cDNA by PCR. All clones analysed represented nested versions of the sequence: 5'-cg cag cgg tcg taa cca agt tgt gtc ctg tca gcc gct gtc ccc ttc gcc gcg atg-3'. The sequence contained in the p44 S10 clone isolated from transformed cells is shown in bold, with the presumed initiator methionine underlined. An in-frame stop codon (underlined) was identi®ed 42 bases upstream, con®rming that the isolated p44 S10 cDNA contains the full-length open reading frame and is predicted to express the full-length polypeptide. Reverse transcription and PCR revealed identical sequence for the p44 S10 protein coding region in each of the four breast cancer cell lines used for library construction and in several melanoma cell lines with or without gene ampli®cation (not shown).
Comparison with sequence in the nonredundant database by tblastn detected matches in cosmids or cDNAs from C. elegans, S. pombe and S. cerevisiae (accessions Z68227, Z14827, Z69909, D89258 and U32445). The predicted polypeptides from these species were very similar in size to human p44 S10 , which contains 389 residues, and were identical in sequence in 40 ± 47% of residues. As previously shown for the human subunit, the homologous S. cerevisiae sequence was recently con®rmed as proteasome regulatory particle subunit RPN7 by denaturing gel electrophoresis and amino acid sequence analysis of the puri®ed proteasome (Dubiel et al., 1995; Glickman et al., 1998b) .
In contrast to RAS or GLI expression vectors, transfection of p44 S10 constructs alone into RK3E cells did not reproducibly induce focus formation, growth in soft agar, or tumorigenicity in nude mice (not shown). Likewise, no eect of p44 S10 was detected after transfection of NIH3T3 cells or cotransfection with E1A into primary rat kidney cells (Ruppert et al., 1991) . Results of these experiments suggested that p44 S10 expression alone is not sucient to induce transformation in vitro.
Chromosomal localization of p44 S10 Southern blot analysis of MCF-7 cells revealed increased p44 S10 gene copy number (see below). Previous chromosome hybridization studies showed that at least three loci are ampli®ed in MCF-7 cells, 3p14, 17q22-24 and 20q13 (Guan et al., 1994; Kallioniemi et al., 1994) . Competitive PCR and cDNA-derived primers were used to amplify an intron-containing fragment from genomic DNA samples of human-rodent somatic cell hybrid (SCH) or . (a) p44 S10 transcripts were detected in total RNA using a cDNA probe. Arrows indicate the position of endogenous rat (arrow 1) or transgenederived human (arrows 2 ± 3) transcripts. The rat transcript migrated at 1.4 kb and served as a control for RNA loading. Lane 1: RK3E. Lane 2: a transformed RK3E cell line from which p44 S10 was isolated. Lanes 3 and 4: RAS transformed RK3E cell lines. (b) Northern blot analysis of p44 S10 in breast cancer cell lines. The ®lter was reprobed with human b-tubulin to control for RNA loading yeast cell lines containing de®ned chromosomes or chromosome regions. A SCH monochromosome mapping panel localized the gene to chromosome 3; a SCH panel containing dierent portions of chromosome 3 localized the gene to 3p14.1-2; contiguous YAC clones spanning 3p14 mapped the gene to the speci®c CEPH YACs (Figure 2 ). Positive clones included 371h4, 879h10, 927e1, 924b12, 882d9, 965h3, 936c10, 977c8, 846g11, 403b2, and 965a3, and no discordances with mapped YACs were observed (Bardenheuer et al., 1996) . The p44 S10 locus in 3p14.1 is approximately 1 ± 2.7 Mb proximal to the t3;8 translocation breakpoint, as de®ned by alignment of non-overlapping and nonchimeric YACs (144g3, 166g8, 130h11, 850a6). The t3;8 breakpoint is within the FHIT candidate tumor suppressor gene that undergoes allelic loss and homozygous deletion in many tumor types (Sozzi et al., 1998) .
Gene amplification of p44 S10
Previously, dinucleotide repeat ampli®cation analysis identi®ed 3p14 regional gain in cutaneous malignant melanoma (personal communication, Kay Huebner, Jeerson Cancer Institute). We therefore tested malignant melanoma cell lines by Southern blot analysis using p44 S10 cDNA probe and a control C-MYC (chromosome 8q24) probe in the same hybridization mixture (Figure 3a , top panel). In ®ve of the 13 melanoma cell lines tested, Mel28, WM9, WM115, WM164 and 451Lu, the ratio of the signal intensity of p44 S10 to C-MYC was increased, suggesting a copy number increase of p44 S10 . Subsequent hybridization of the same ®lter to C-RAF-1 (chromosome 3p25) did not detect the copy number increases, indicating the copy number alteration is segmental ( Figure 3a , bottom panels). The signal intensity ratio of C-RAF to p44 S10 is greater than one for samples without ampli®cation, but less than one for samples with copy number gain.
To quantitate the copy number increase, we compared the copy number of the p44 S10 locus (3p14.1, *91 cM from the 3p telomere) with the copy number of¯anking control probes derived from 3p12-14 (proximal control, 108 ± 111 cM from the 3p telomere), and from 3p21 (distal control, 63 ± 67 cM from 3p telomere) (Wong et al., 1986; Schuler et al., 1996) . DNA from melanoma cell lines was directly bound to nitrocellulose membrane and hybridized to p44 S10 ( Figure 3b ). The ®lter was stripped and genomic DNA was digested with EcoRV and analysed using a hybridization mixture containing p44 S10 and C-MYC (chromosome 8q24) probes. Bottom panel: the ®lter was stripped and hybridized to a C-RAF-1 cDNA probe (chromosome 3p25). The largest and smallest of the ®ve C-RAF-1 speci®c bands are shown. NL: normal lymphocyte DNA. MDA-MB-231 and MCF-7 are breast cancer cell lines. Other lines are derived from cutaneous malignant melanoma. Molecular size in kilobases is indicated on the left. (b) Slot blot analysis of melanoma cell lines. DNA was applied in duplicate to a nitrocellulose ®lter and hybridized sequentially to p44 S10 (91 cM from 3p telomere, left), a proximal control probe (108 ± 111 cM from 3p telomere, middle), and a distal control probe (63 ± 67 cM from 3p telomere, right). (c) Dierential PCR analysis of melanoma cell lines. Ampli®ed p44 S10 and g-IFN (chromosome 12q) fragments were separated by electrophoresis and visualized by autoradiography. Odd lanes: reactions contained the primer pairs for p44 S10 and an IFN 85 bp fragment. Even lanes: reactions contained primer pairs for IFN 85 and 150 bp fragments successively rehybridized to the two control probes. For the exposures shown, the control probes yielded a similar signal as p44 S10 on normal lymphocyte DNAs (NL1 and NL2). However, the p44 S10 probe yielded a greater signal on DNAs from MCF-7, Mel28, WM9, WM115, WM164 and 451Lu. After normalizing for DNA loading using the proximal control probe, the mean apparent ampli®cation of p44 S10 was determined to be: MCF-7: 11.27, Mel28: 2.45, WM9: 2.18, WM115: 1.83, WM164: 2.46, 451Lu: 2.31. Similar results were obtained after normalizing to the distal control probe. In contrast, the p44 S10 copy number in other cell lines or lymphocyte samples were estimated as 0.8 ± 1.2-fold relative to control probes as previously described for this method (Wong et al., 1986) .
The ampli®cation in melanoma cell lines apparent by Southern and slot blot analysis was further con®rmed by a dierential polymerase chain reaction (PCR) assay (Figure 3c) . A p44 S10 gene fragment of 115 bp and a control locus, the g-interferon (IFN) gene on chromosome 12q, were co-ampli®ed in the same PCR reaction. Primer sets from the IFN locus generated either 150 bp or 85 bp products (Neubauer et al., 1992) . One primer for each product was end-labelled with g 32 P ATP to allow detection during the exponential phase of the reaction. In MCF-7, Mel28, 451Lu and WM164, the p44 S10 yield was increased relative to IFN. For WM35, which exhibited no apparent copy number increase by Southern or slot blot analysis (see above), the p44 S10 yield was similar to that from normal lymphocyte DNA. In contrast, all of these samples exhibited similar yield of control products (IFN 85 and 150).
In summary, the results showed that p44 S10 is ampli®ed in melanoma cell lines relative to multiple chromosome 3p markers, a 3q marker (data not shown), the C-MYC locus on chromosome 8q24, and the IFN locus on chromosome 12q.
We next tested for p44 S10 ampli®cation using DNA from fresh-frozen surgical samples of malignant melanoma primary or metastatic tumors by Southern blot analysis as above for cell lines (Figure 4a, top  panel) . In 61T, a regional metastasis, intensity of the p44 S10 signal was increased relative to both C-MYC and C-RAF-1 (3p25) (Figure 4a, bottom panels) . Quantitation of the p44 S10 copy number by slot blot analysis using C-MYC hybridization to normal lymphocyte DNA as control revealed 2.3-fold ampli®-cation (Figure 4b) .
We further analysed these tumor DNAs by slot blot analysis (Figure 4c, top panel) . The ®lter was successively hybridized to p44 S10 and a control probe derived from 3q25-26 (Schuler et al., 1996) . Hybridization to p44 S10 , but not to the control, was increased for 61T. Similar results were obtained using the distal control probe from 3p21 ( Figure 4c, bottom panel) . The speci®c copy number increase of p44 S10 relative to both 3q and distal control probes con®rmed gene ampli®cation of p44 S10 in 61T. Quantitation revealed that the apparent copy number of p44 S10 relative to the distal control is increased by 2.4-fold in 61T. As this tumor was estimated to contain 30 ± 40% stromal cells after microdissection, the fold increase in malignant cells may be higher. For this tumor, but for no other samples with p44 S10 ampli®cation, copy number of the . DNA was applied in duplicate or triplicate to nitrocellulose membrane and then hybridized sequentially to p44 S10 and control probes. Each row of ®lters represents an independent experiment, and each result shown was con®rmed using independently prepared slot blots. (b) The ®lter was hybridized sequentially to p44 S10 and C-MYC (chrom. 8q24) probes. (c) Top panel: The ®lter was hybridized sequentially to p44 S10 and a control probe from 3q25-26. Bottom panel: The ®lter was hybridized sequentially to p44 S10 and a distal control probe. (d) DNA from paran-embedded tumors or normal lymphocytes (NL) was applied to a ®lter and hybridized sequentially to p44 S10 , the chromosome 3p proximal control probe, and the distal control probe proximal 3p control probe was likewise increased. This suggests that the ampli®cation unit can extend proximal of p44 S10 by a distance of several cM in a subset of cases.
We also tested paran-embedded melanoma tumor samples for p44 S10 ampli®cation as described (Wong et al., 1986) . Slot blots were prepared and the ®lter was sequentially hybridized to p44 S10 , proximal control probe, and distal control probe (Figure 4d ). Compared to both controls, p44 S10 hybridized more eciently to PP12, a local recurrence of a primary tumor. Quantitation revealed the copy number of p44 S10 is increased by 1.8-fold in PP12.
In total, p44 S10 ampli®cation was observed in one fresh-frozen tumor of 25 tested and in one paranembedded specimen of 15 tested. The results shown in Figures 3 and 4 are representative of multiple independent determinations of p44 S10 copy number in tumors and cell lines (other results not shown). These same studies detected increased copies of C-MYC in *10% (4/40) of melanoma tumors (for example, tumor 62T in Figure 4a ,b). In contrast to p44 S10 , copy number alterations of C-MYC in melanoma appeared non-segmental, as shown by hybridization of other chromosome 8q probes (data not shown).
By Northern blot analysis, expression of p44 S10 was speci®cally increased in each of the cell lines with gene ampli®cation (Mel28, WM9, WM115, WM164 and 451Lu) (Figure 5a ). Comparison of timed exposures revealed that Mel28 cells exhibited *3-fold higher expression than the cell lines without ampli®cation. Interestingly, each of the other four melanoma cell lines with ampli®cation exhibited a greater increase (*10-fold) in expression, comparable to that of MCF-7 cells containing 11-fold gene ampli®cation.
We also tested for expression of p44 S10 in normal human tissues by Northern blot analysis (Figure 5b ). Relative to the b-tubulin control, expression of p44 S10 in pancreas and skeletal muscle was high, whereas expression in brain and lung was low. Therefore, expression of this gene is regulated in a tissue-speci®c fashion.
Activation of p44 S10 in a model of malignant progression Nontumorigenic WM35 cells, derived from human radial growth phase melanoma cells, were previously treated by retroviral insertional mutagenesis followed by selection for growth of solid tumors in nude mice (Bani et al., 1996) . In a small subset of animals, highly aggressive and phenotypically stable tumorigenic variants were derived that exhibited multiple features of advanced-stage melanoma cells, including growth factor and anchorage independence, MUC18 overexpression, and resistance to multiple growth-inhibitory cytokines. Cell lines derived from these tumors were highly tumorigenic after reinjection into animals. Compared to WM35 cells or control populations (WM35-G or -E) that were selected in culture after retroviral transduction, tumorigenic variant lines (3.1D1, 3.1D2 and 4.1) exhibited increased p44 S10 transcripts and increased gene copy number ( Figure  6a,b) . To determine whether increased expression of p44 S10 in WM35 cells was sucient to recapitulate all or part of the malignant phenotype, WM35 cells were transduced with high titre p44 S10 retroviral supernatants or controls. For each of two independent transfection/ transduction/selection experiments, WM35 cells were selected in G418 and more than 1000 resistant colonies were pooled and tested for growth in nude mice. Unlike antisense and vector control constructs, the sense construct signi®cantly stimulated proliferation of WM35 cells in vivo (Figure 6c ) (F=10.17, p50.001). As previously published, WM35 cells or control populations typically formed no visible lesion or formed small,¯at or elongated lesions 5100 mg in size (Bani et al., 1996) . In comparison to p44 S10 -transduced cells, which typically formed tumors in 12 ± 16 weeks, a tumorigenic variant line used as a positive control reproducibly formed tumors 41.0 gr in size within 4 ± 8 weeks post-injection. Consistent with their moderately aggressive behavior in vivo, p44 S10 -sense cells did not eciently survive prolonged incubation in reduced serum in vitro as observed for variant cells (Bani et al., 1996) (not shown).
Analysis of two tumors excised from mice at 16 weeks post-injection revealed that expression of the sense transcript was retained (Figure 6d, upper arrow) , and that the endogenous transcript was not signi®-cantly up-regulated (lower arrow).
Discussion
We identi®ed p44 S10 as the only human cDNA detectable in a morphologically transformed RK3E clone. However, no consistent phenotype resulted from re-introduction of the cloned cDNA into RK3E or into other rodent host cells as described in the Results. Isolation of the gene was perhaps facilitated by coexpression of other library-derived genes (although these were not detected by PCR as stably integrated cDNAs), by an increased susceptibility to transformation in a small subpopulation of RK3E cells, or by alteration of the RK3E genome coincident with transfection.
Our interest in this gene was triggered by observation of gene ampli®cation in melanoma cell lines and tumors. The observed ampli®cation was demonstrated to be segmental in all cases, and was associated with signi®cantly increased expression of p44 S10 transcripts, even though the fold of ampli®cation in melanoma samples was moderate (1.80 ± 2.46). The disproportionate increase of p44 S10 transcripts in these samples suggests that the extra gene copies may be preferentially transcribed, perhaps owing to rearrangement proximal to a transcriptional enhancer or to altered chromatin structure, and suggests that the low-level gene ampli®ca-tion observed here may be more analogous to chromosome translocations that similarly activate transcription of a single allele for other oncogenes. Although 3p14 was previously shown to be ampli®ed in MCF-7 cells, no ampli®cation in other breast cancer cell lines or tumors was detected by us (unpublished results) (Guan et al., 1994; Kallioniemi et al., 1994) .
Further evidence implicating p44 S10 in the malignant phenotype was obtained by the presence of increased gene copy number and abundant mRNA transcripts in tumorigenic variants of radial growth phase WM35 cells (Bani et al., 1996) . Although gene ampli®cation likely activates expression of multiple linked genes Figure 6 Activation of p44 S10 in a model of melanoma progression. (a) Total RNA was prepared from the indicated human melanoma cell lines and analysed by Northern blot. The ®lter was hybridized with GAPDH as a control for loading. (b) Genomic DNA from the indicated melanoma cell lines was digested with EcoRI, separated electrophoretically and transferred to nitrocellulose. The ®lter was ®rst hybridized with a p44 S10 probe and then with the C-MYC probe. (c) WM35 cells stably transduced with p44 S10 sense, antisense, or vector controls were inoculated under the skin of athymic mice. Results from two dierent retroviral transduction experiments are shown. Symbols centered on the y-axis origin indicate no visible lesion. (d) Expression of p44 S10 in WM35-derived cell lines and tumors. RNA was isolated from the indicated sample and analysed by Northern blot. The position of migration of 18S and 28S ribosomal RNAs are indicated. Ethidium-stained RNA attached to the ®lter is shown below. Partial degradation of samples in lanes 5 ± 6 was attributed to central necrosis in the nude mouse tumors. Lanes: 1, WM35 cells; 2 ± 4, respectively, sense, antisense, and vector-expressing WM35 cells from transduction experiment 1; 5 ± 6, two tumors excised after injection of sense-expressing cells; 7, MCF-7 cells. Arrowheads indicate endogenous p44 S10 (lower) and transgene-derived transcripts (upper) within 3p14, p44 S10 represents an attractive candidate as a target gene since forced expression in radial growth phase WM35 cells resulted in markedly increased proliferation in vivo. Potentially, p44 S10 may act to increase proliferation in vivo and thereby increase the probability of additional genetic alterations and the outgrowth of more malignant cells (Bani et al., 1996) . Further molecular analysis of WM35 cells and variants may help to identify the nature of these additional genetic changes.
The function of p44 S10 as a proteasome regulatory particle subunit suggests a potential link between regulation of proteasome activity and tumor cell proliferation in vivo. The proteasome is composed of a 20S proteolytic core particle and a 19S regulatory particle (Hochstrasser, 1996; Coux et al., 1996; Glickman et al., 1998a ). The yeast regulatory particle can be further subdivided into a core-proximal base and a distal cap composed of the p44 S10 homologue RPN7 and seven other subunits. The distal cap is required for ubiquitin-dependent degradation but is dispensable for ubiquitin-independent proteolysis. Since these distal subunits are dispensable for proteolysis, they represent attractive candidate regulators of proteasome activity and may function in signaling or in docking to other particles (Glickman et al., 1998a) .
The other p44 S10 -and yeast RPN7-related sequences are homologues of Arabidopsis fus6/cop11 (accessions L26498, X87885, U20285). fus6/cop11 is found in a large multiprotein complex with cop9 and functions in lightmediated signaling and transcriptional regulation (Chamovitz et al., 1996) . This cop9 complex or`signalosome' is highly conserved in mammalian cells, possesses multiple subunits with similarity to the proteasome regulatory particle, and exhibits kinase activity for proteasome-regulated proteins including NFkB, IkBa, and the amino-terminal activation domain of c-Jun (Seeger et al., 1998) . p44 S10 is 22% identical to fus6 overall. A more striking similarity occurs at residues 240 ± 348 (32% identical and 57% similar/identical), representing the PINT/PCI domain present in components of multisubunit complexes such as the proteasome, the translation initiation factor eIF3, and the cop9/ signalosome (Glickman et al., 1998a) . While it remains to be determined whether up-regulation of p44 S10 expression aects proteasome function, the expression of many growth-regulatory proteins are regulated by the proteasome pathway, including cyclins, CDK inhibitors, p53, NF-kB, c-Fos, c-Jun, and others (Hochstrasser, 1996; Coux et al., 1996; Glickman et al., 1998b) . Consistent with a role for proteasome activity in tumor progression is the regulation of G1-S and M phase cell cycle transitions by ubiquitin-mediated degradation of multiple cellular proteins such as the G1 CDK inhibitor SIC1 (King et al., 1996) .
Although p44 S10 is highly conserved in evolutionarily distant species, and the proteasome is likely important to all cells, our results show that p44 S10 expression varies greatly in dierent normal tissues (Figure 5b ). In addition, several other proteasome subunits (RPN4, RPN9, RPN10) are nonessential for viability in yeast (Glickman et al., 1998b) . These results suggest that gene knockout studies might be used to modulate p44 S10 expression for analysis of phenotypic eects in other melanoma model systems (Chin et al., 1997) . Assessment of p44 S10 copy number and expression during tumor progression will lead to a better understanding of the frequency and timing of p44 S10 activation in patients, and may identify a subset of patients with a distinct prognosis.
Materials and methods
Construction of a cDNA expression library
The cDNA library used in these studies was described previously (Foster et al., 1999) . Poly A+ mRNA from four breast cancer cell lines (MCF-7, MDA-MB-453, T47D and ZR75-1, obtained from the American Type Culture Collection [ATCC], Rockville, MD, USA) was converted into cDNA and cloned into bacteriophage lambda using the ZAP Express cDNA Synthesis Kit (Stratagene, La Jolla, CA, USA), and a directional library in pBKCMV was used for transfection.
Fractions of the library representing a total of 1610 6 independent clones were transfected into 170 dishes of exponentially growing RK3E cells using adenovirus particles conjugated to polylysine (AdpL) (Deshane et al., 1994) . Cell culture and scoring of focus formation was as described (Ruppert et al., 1991) . 1.5610 10 puri®ed AdpL particles (strain Ad5del-1014, deleted in the E4 region, 1 O.D.@260=1610 12 /ml) were mixed with 9 mg of plasmid for each 10 cm dish of cells, resulting in transient transfection of 430% of cells, and stable transfection of 4500 cells per dish as indicated by focus formation (Ruppert et al., 1991) .
cDNA retrieval from transformed cells PCR reactions were carried out as described (Barnes, 1994) . 50 ng of genomic DNA was subjected to ampli®cation using T7 and T3 primers. PCR products were cloned into pDirect (Clontech, Palo Alto, CA, USA) as recommended by the manufacturer.
Chromosome localization of p44 S10 by competitive PCR PCR primers (5'-aggcagctgaactcttcc-3' and 5'-cttcaagaatctctgctcct-3') were derived from exons separated by an intron of *100 basepairs. 50 ng of genomic DNA were used for each reaction. To limit false positive signals, reaction mixtures contained the p44 S10 cDNA (2.5610 75 fmol per reaction). The PCR products were resolved in a 2% agarose gel and stained with ethidium bromide. YAC DNAs were ®rst analysed as 28 pools of 20 clones each, then subsequently as single clones.
Southern blot and Northern blot
Thirteen melanoma cell lines were obtained from the American Type Culture Collection or from Meenhard Herlyn (Wistar Institute, Philadelphia, PA, USA). Genomic DNA was isolated from microdissected tumor samples and analysed by Southern blot as described (Ruppert et al., 1988) . Total RNA was isolated and 20 ± 25 mg of each sample was denatured and separated on formaldehyde-agarose gels and then transferred to nitrocellulose membrane by rapid downward transfer (Schleicher & Shuell, Keene, NH, USA) (Chomczynski and Sacchi, 1987) .
Slot blot analysis
DNA was extracted from microdissected fresh-frozen tumors or paran-embedded tumor as described (Wong et al., 1986) . 1.5 ± 5 mg of DNA were brought to a ®nal concentration of 0.4 M NaOH, 10 mM EDTA in a volume of 200 ml, then heated for 10 min at 1008C. The samples were neutralized by the addition of an equal volume of cold 2 M ammonium acetate (pH 7.0) and applied to a nitrocellulose membrane with a Minifold-II apparatus (Schleicher & Shuell) as recommended by the manufacturer (Wong et al., 1986) . Washed ®lters were analysed by autoradiography and quantitated by phosphorimager analysis (Molecular Dynamics).
DNA probes
A PstI fragment of the C-MYC second exon was obtained from Donald Miller (University of Alabama at Birmingham). C-RAF-1 cDNA was obtained from Andrew Kraft (University of Colorado at Denver). Control probes for slot blot analysis of melanoma cell lines and tumors were obtained from Research Genetics (Huntsville, AL, USA): 3p12-14 (108 ± 111 cM from 3p telomere), IMAGE 211755; 3p21 (63 ± 67 cM from 3p telomere), IMAGE 32991; 3q25-26, IMAGE 327355. Each IMAGE probe was previously mapped to the indicated interval using more than one mapping reagent (Schuler et al., 1996) .
Differential PCR (Figure 3c) The PCR primers for p44 S10 were derived from cDNA sequence: 5'-aggcagctgaactcttcc-3' (forward primer), 5'-ggtctttctaaggcaatcata-3' (reverse primer). g-IFN primers were as described (Neubauer et al., 1992) . Reactions contained p44 S10 and the IFN 85 primer pairs or, alternatively, IFN 85 and 150 primer pairs, with 2.5 ng of end-labelled forward primers, 300 ng of each of the four unlabelled primers and 200 ng of genomic DNA. Primers were end-labelled with a sub-stoichiometric amount of g 32 P ATP (3000 Ci/mmol) using T4 polynucletide kinase and used for PCR without further puri®cation. The pro®le included only 22 ± 26 cycles and resulted in subnanogram yields of PCR product. The PCR products were resolved on a 16% polyacrylamide native gel, ®xed, dried and visualized by autoradiography.
Transduction of WM35 cells and analysis of tumorigenicity in vivo
A p44 S10 cDNA fragment corresponding to bases 726 to+1215 (where the ATG initiator codon=1) was inserted in both orientations in the Moloney muring leukemia retroviral vector pLJ(D), and the sequence of the ®nal construct was veri®ed (Cheng et al., 1995) . For each of the two experiments, high-titre retroviral supernatants were generated independently by transient transfection of BOSC23 ecotropic packaging cells, and transferred onto AM12 amphotropic packaging cells (Pear et al., 1993) . After selection in G418 for 6 days, colonies were pooled and supernatants were transferred onto WM35 cells followed by G418 selection as described (Bani et al., 1996) . More than 1000 drug-resistant colonies were trypsinized en masse and pooled to generate each population. The two transfection/ transduction/selection experiments were performed at dierent times, indicated as experiments 1 and 2. 1610 6 cells were injected per site as described (Bani et al., 1996) . Tumors were scored at 16 ± 20 weeks after injection. Analysis of variance techniques revealed signi®cant dierences in tumor formation (F=10.17, P50.001). Multiple comparisons, speci®cally the Newman ± Kuels test, indicated that sense-expressing cells were signi®cantly dierent from the two controls (Montgomery, 1991) . No signi®cant dierence existed between the vector and antisense assays. Using the same cell lines, in vivo results consistent with those shown in Figure 6c were obtained in a smaller pilot injection experiment (not shown).
Accession number
Sequence for p44 S10 was submitted to Genbank (AF215935) and Italian Association for Cancer Research (M Rosa Bani.
